Commerce Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $982K | Buy |
7,685
+4,425
| +136% | +$552K | ﹤0.01% | 720 |
|
|
2025
Q4 | $397K | Buy |
3,260
+90
| +3% | +$10.3K | ﹤0.01% | 955 |
|
|
2025
Q3 | $318K | Buy |
3,170
+15
| +0.5% | +$1.35K | ﹤0.01% | 1039 |
|
|
2025
Q2 | $262K | Sell |
3,155
-1,201
| -28% | -$95.8K | ﹤0.01% | 1083 |
|
|
2025
Q1 | $353K | Buy |
4,356
+1,164
| +36% | +$104K | ﹤0.01% | 965 |
|
|
2024
Q4 | $287K | Buy |
3,192
+37
| +1% | +$3.58K | ﹤0.01% | 1038 |
|
|
2024
Q3 | $312K | Sell |
3,155
-439
| -12% | -$43.1K | ﹤0.01% | 1046 |
|
|
2024
Q2 | $333K | Hold |
3,594
| – | – | ﹤0.01% | 994 |
|
|
2024
Q1 | $341K | Hold |
3,594
| – | – | ﹤0.01% | 981 |
|
|
2023
Q4 | $321K | Hold |
3,594
| – | – | ﹤0.01% | 992 |
|
|
2023
Q3 | $262K | Hold |
3,594
| – | – | ﹤0.01% | 999 |
|
|
2023
Q2 | $299K | Hold |
3,594
| – | – | ﹤0.01% | 973 |
|
|
2023
Q1 | $274K | Buy |
3,594
+150
| +4% | +$12.4K | ﹤0.01% | 1014 |
|
|
2022
Q4 | $286K | Sell |
3,444
-11
| -0.3% | -$891 | ﹤0.01% | 994 |
|
|
2022
Q3 | $274K | Sell |
3,455
-60
| -2% | -$5.06K | ﹤0.01% | 976 |
|
|
2022
Q2 | $261K | Buy |
3,515
+60
| +2% | +$4.5K | ﹤0.01% | 1004 |
|
|
2022
Q1 | $311K | Buy |
3,455
+257
| +8% | +$23.7K | ﹤0.01% | 988 |
|
|
2021
Q4 | $358K | Buy |
3,198
+10
| +0.3% | +$1.21K | ﹤0.01% | 966 |
|
|
2021
Q3 | $401K | Sell |
3,188
-131
| -4% | -$16.9K | ﹤0.01% | 905 |
|
|
2021
Q2 | $449K | Sell |
3,319
-896
| -21% | -$118K | ﹤0.01% | 872 |
|
|
2021
Q1 | $572K | Buy |
4,215
+308
| +8% | +$46.1K | ﹤0.01% | 762 |
|
|
2020
Q4 | $550K | Buy |
3,907
+67
| +2% | +$8.58K | ﹤0.01% | 744 |
|
|
2020
Q3 | $428K | Buy |
3,840
+10
| +0.3% | +$1.12K | ﹤0.01% | 741 |
|
|
2020
Q2 | $429K | Sell |
3,830
-50
| -1% | -$4.92K | ﹤0.01% | 727 |
|
|
2020
Q1 | $300K | Hold |
3,880
| – | – | ﹤0.01% | 758 |
|
|
2019
Q4 | $369K | Hold |
3,880
| – | – | ﹤0.01% | 753 |
|
|
2019
Q3 | $296K | Hold |
3,880
| – | – | ﹤0.01% | 780 |
|
|
2019
Q2 | $340K | Hold |
3,880
| – | – | ﹤0.01% | 730 |
|
|
2019
Q1 | $351K | Hold |
3,880
| – | – | ﹤0.01% | 676 |
|
|
2018
Q4 | $278K | Hold |
3,880
| – | – | ﹤0.01% | 708 |
|
|
2018
Q3 | $372K | Hold |
3,880
| – | – | ﹤0.01% | 674 |
|
|
2018
Q2 | $369K | Sell |
3,880
-238
| -6% | -$21.9K | ﹤0.01% | 664 |
|
|
2018
Q1 | $361K | Hold |
4,118
| – | – | ﹤0.01% | 662 |
|
|
2017
Q4 | $349K | Buy |
4,118
+1,000
| +32% | +$83.8K | ﹤0.01% | 676 |
|
|
2017
Q3 | $270K | Hold |
3,118
| – | – | ﹤0.01% | 728 |
|
|
2017
Q2 | $241K | Sell |
3,118
-524
| -14% | -$37.2K | ﹤0.01% | 755 |
|
|
2017
Q1 | $253K | Hold |
3,642
| – | – | ﹤0.01% | 729 |
|
|
2016
Q4 | $216K | Buy |
3,642
+378
| +12% | +$23.3K | ﹤0.01% | 749 |
|
|
2016
Q3 | $216K | Buy |
+3,264
| New | +$202K | ﹤0.01% | 752 |
|
Other funds holding XBI
Commerce Bank's XBI Position: Q1 2026 in Review
Commerce Bank increased its State Street SPDR S&P Biotech ETF (XBI) stake by 136% in Q1 2026, buying an estimated $552K and bringing the position to 7,685 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #720.
Commerce Bank first reported a position in XBI in Q3 2016 and has held it in 39 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Commerce Bank held 7,685 shares of State Street SPDR S&P Biotech ETF worth $982K as of Q1 2026.
- Commerce Bank bought 4,425 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $552K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #720 holding.
- Commerce Bank first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and has held it in 39 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.